Ranitidine Dose: 1 mg/kg per dose
The recommended ranitidine dose is 1 mg/kg per dose, administered intravenously over 5 minutes, which can be diluted in 5% dextrose to a total volume of 20 mL. This dosing is specifically established for the management of anaphylaxis in pediatric patients 1.
Context-Specific Dosing
For Anaphylaxis (Primary Indication in Guidelines)
- Dose: 1 mg/kg per dose IV
- Administration: Dilute in D5W to 20 mL total volume, inject over 5 minutes
- Maximum: 12.5-50 mg in children (depending on weight) 1
- Adult dose: 50 mg 1
- Important caveat: Ranitidine is second-line therapy to epinephrine and should never be used alone in anaphylaxis. The combination of diphenhydramine and ranitidine is superior to diphenhydramine alone 1
For GERD and Gastric Acid Suppression (FDA-Approved)
The FDA-approved dosing varies by indication 2:
Treatment of GERD/Erosive Esophagitis in children (1 month-16 years):
- 5-10 mg/kg/day divided in 2 doses 2
- This aligns with guideline recommendations of 5-10 mg/kg/day for GERD treatment 3
Treatment of Duodenal/Gastric Ulcers in children:
- 2-4 mg/kg twice daily (maximum 300 mg/day) 2
Maintenance therapy:
- 2-4 mg/kg once daily (maximum 150 mg/day) 2
Critical Care Considerations
For critically ill children requiring stress ulcer prophylaxis, research evidence suggests higher dosing may be necessary:
- Minimum 3 mg/kg/day IV is needed for adequate gastric pH control (pH >4) in pediatric ICU patients 4
- The commonly cited 2-4 mg/kg/day resulted in poor pH control in 36% of critically ill children 4
- For optimal prophylaxis: 1.5 mg/kg IV every 6 hours (total 6 mg/kg/day) achieved pH ≥4 in 80% of critically ill children 5
Important Clinical Pitfalls
Insufficient dosing in critical illness: The standard 2-4 mg/kg/day may be inadequate for critically ill children with normal renal/hepatic function. Consider titrating to gastric pH monitoring 4
Renal adjustment required: For creatinine clearance <50 mL/min, reduce to 150 mg every 24 hours in adults; pediatric dosing should be proportionally adjusted 2
Neonates (<1 month): Insufficient pharmacokinetic data exists for dosing recommendations 2. If used, 2 mg/kg/24 hours as continuous infusion maintained adequate pH in term neonates on ECMO 6
Duration of effect: Doses ≥3 mg/kg may be required for acid suppression lasting beyond 6 hours 7
Age-appropriate formulations: Ranitidine is available as peppermint-flavored syrup for pediatric use 3